Immunophenotypic shifts from diagnosis to relapse have been previously reported in both adult and childhood AML; often, CD117, CD13, and CD34 are the most variable markers (Baer et al, 2001; Langebrake et al, 2005; Martínez-Losada et al, 2018). Here, ANPEP is linked to acute myeloid leukemia.